Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
11.53
+0.03 (0.26%)
Feb 4, 2026, 3:00 PM CST
SHA:603811 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 205.13 | 173.04 | 294.14 | 213.51 | 83.32 | 72.31 |
Cash & Short-Term Investments | 205.13 | 173.04 | 294.14 | 213.51 | 83.32 | 72.31 |
Cash Growth | -1.34% | -41.17% | 37.77% | 156.25% | 15.23% | -48.75% |
Accounts Receivable | 46.96 | 72.91 | 93.18 | 90.44 | 78.79 | 78.68 |
Other Receivables | 2.1 | 6.47 | 2.87 | 1.28 | 1.33 | 0.86 |
Receivables | 49.06 | 79.38 | 96.05 | 91.72 | 80.12 | 79.54 |
Inventory | 125.32 | 131.84 | 116.78 | 111.04 | 117 | 119.26 |
Other Current Assets | 16.67 | 9.36 | 10.45 | 20.57 | 7.35 | 11.2 |
Total Current Assets | 396.18 | 393.62 | 517.42 | 436.84 | 287.8 | 282.31 |
Property, Plant & Equipment | 894.69 | 945.69 | 1,003 | 919.65 | 668.66 | 593 |
Long-Term Investments | 331.72 | 314.87 | 281.13 | 234.01 | 208.2 | 204.72 |
Goodwill | - | - | - | - | 2.42 | 5.33 |
Other Intangible Assets | 53.51 | 63.95 | 66.66 | 68.45 | 70.19 | 69.95 |
Long-Term Deferred Tax Assets | 5.73 | 6.3 | 5.94 | 17.47 | 5.16 | 4.91 |
Long-Term Deferred Charges | 0.25 | 0.41 | 1.43 | 1.44 | 2.24 | 1.29 |
Other Long-Term Assets | 9.52 | 3.55 | 17.55 | 41.24 | 77.83 | 45.39 |
Total Assets | 1,692 | 1,728 | 1,893 | 1,719 | 1,322 | 1,207 |
Accounts Payable | 49.89 | 84.67 | 118.91 | 54.79 | 57.5 | 61.11 |
Accrued Expenses | 13.82 | 78.28 | 76.15 | 79.75 | 72.57 | 91.16 |
Short-Term Debt | 55.1 | 51.1 | 117.33 | 76.5 | 86.36 | 40.87 |
Current Portion of Long-Term Debt | 3.06 | 40.43 | 8.91 | 14.02 | - | - |
Current Portion of Leases | - | 0.02 | 0.75 | 0.61 | 0.76 | - |
Current Income Taxes Payable | 17.9 | 6.4 | - | - | 7.83 | 11.24 |
Current Unearned Revenue | 8.53 | 12.22 | 4.38 | 13.74 | 6.11 | 4.81 |
Other Current Liabilities | 126.69 | 18.38 | 16.22 | 18.59 | 15.75 | 18.18 |
Total Current Liabilities | 274.99 | 291.5 | 342.65 | 257.99 | 246.87 | 227.38 |
Long-Term Debt | 58.61 | 139.31 | 316.38 | 334.77 | 59.63 | 80.1 |
Long-Term Leases | - | - | 0.47 | 0.91 | 1.79 | - |
Long-Term Unearned Revenue | 16.6 | 18.77 | 21.29 | 16.93 | 12.22 | 11.7 |
Long-Term Deferred Tax Liabilities | 12.51 | 13.74 | 15.37 | 17.56 | 3.11 | 1.62 |
Total Liabilities | 362.71 | 463.31 | 696.15 | 628.16 | 323.62 | 320.79 |
Common Stock | 327.3 | 327.3 | 327.3 | 233.79 | 233.79 | 166.99 |
Additional Paid-In Capital | 122.65 | 143 | 143 | 236.51 | 238.08 | 304.88 |
Retained Earnings | 920.35 | 857.04 | 721.8 | 617.36 | 514.22 | 401.87 |
Treasury Stock | -48.29 | -67.26 | - | - | - | - |
Comprehensive Income & Other | - | - | 0.21 | 0.23 | 0.22 | 0.21 |
Total Common Equity | 1,322 | 1,260 | 1,192 | 1,088 | 986.31 | 873.95 |
Minority Interest | 6.86 | 4.98 | 4.3 | 3.05 | 12.57 | 12.14 |
Shareholders' Equity | 1,329 | 1,265 | 1,197 | 1,091 | 998.88 | 886.09 |
Total Liabilities & Equity | 1,692 | 1,728 | 1,893 | 1,719 | 1,322 | 1,207 |
Total Debt | 116.77 | 230.86 | 443.84 | 426.8 | 148.54 | 120.97 |
Net Cash (Debt) | 88.36 | -57.82 | -149.7 | -213.3 | -65.22 | -48.66 |
Net Cash Per Share | 0.27 | -0.18 | -0.46 | -0.65 | -0.20 | -0.15 |
Filing Date Shares Outstanding | 309.07 | 318.89 | 327.3 | 327.3 | 327.3 | 327.3 |
Total Common Shares Outstanding | 309.07 | 318.89 | 327.3 | 327.3 | 327.3 | 327.3 |
Working Capital | 121.19 | 102.12 | 174.78 | 178.85 | 40.93 | 54.93 |
Book Value Per Share | 4.28 | 3.95 | 3.64 | 3.32 | 3.01 | 2.67 |
Tangible Book Value | 1,269 | 1,196 | 1,126 | 1,019 | 913.7 | 798.67 |
Tangible Book Value Per Share | 4.10 | 3.75 | 3.44 | 3.11 | 2.79 | 2.44 |
Buildings | - | 656.07 | 686.92 | 441.63 | 374.71 | 369.96 |
Machinery | - | 672.02 | 687.58 | 600.01 | 443.66 | 396.15 |
Construction In Progress | - | 5.15 | 6.16 | 182.6 | 99.91 | 27.26 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.